PharmaKinetics Labs
Executive Summary
Product development services toward an NDA for a new compound will be provided by PharmaKinetics for "a leading U.S. pharmaceutical manufacturer," the firm said. Under the agreement, PharmaKinetics will receive $10 mil. plus a royalty on any product sales.